NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,502,028 | +5.5% | 14,746 | +4.5% | 0.15% | +6.4% |
| Q2 2023 | $1,424,042 | +8.7% | 14,112 | -0.9% | 0.14% | +3.7% |
| Q1 2023 | $1,310,080 | +30.1% | 14,240 | +28.3% | 0.14% | +19.3% |
| Q4 2022 | $1,006,811 | +26.6% | 11,098 | +6.1% | 0.11% | +8.6% |
| Q3 2022 | $795,000 | +4.7% | 10,462 | +16.5% | 0.10% | +2.9% |
| Q2 2022 | $759,000 | -14.7% | 8,980 | -11.5% | 0.10% | -5.6% |
| Q1 2022 | $890,000 | +43.1% | 10,148 | +42.7% | 0.11% | +45.9% |
| Q4 2021 | $622,000 | -7.6% | 7,110 | -13.6% | 0.07% | -21.3% |
| Q3 2021 | $673,000 | -7.8% | 8,232 | +2.9% | 0.09% | -11.3% |
| Q2 2021 | $730,000 | +11.1% | 8,000 | +4.0% | 0.11% | -0.9% |
| Q1 2021 | $657,000 | -3.1% | 7,690 | +7.1% | 0.11% | -15.1% |
| Q4 2020 | $678,000 | +9.2% | 7,178 | +0.5% | 0.13% | -6.7% |
| Q3 2020 | $621,000 | -9.9% | 7,144 | -9.4% | 0.14% | -11.2% |
| Q2 2020 | $689,000 | -67.4% | 7,888 | -69.2% | 0.15% | -56.9% |
| Q1 2020 | $2,111,000 | -4.6% | 25,618 | +8.4% | 0.35% | +32.2% |
| Q4 2019 | $2,213,000 | +13.7% | 23,636 | +4.8% | 0.27% | -10.7% |
| Q3 2019 | $1,946,000 | -2.8% | 22,558 | +2.2% | 0.30% | -5.7% |
| Q2 2019 | $2,002,000 | +12.9% | 22,071 | +18.7% | 0.32% | +1.6% |
| Q1 2019 | $1,774,000 | +52.4% | 18,601 | +35.5% | 0.31% | +0.6% |
| Q4 2018 | $1,164,000 | +163.9% | 13,727 | +159.4% | 0.31% | +146.0% |
| Q3 2018 | $441,000 | +19.8% | 5,291 | +4.2% | 0.13% | -2.3% |
| Q2 2018 | $368,000 | -8.7% | 5,078 | -1.8% | 0.13% | -11.6% |
| Q1 2018 | $403,000 | +4.1% | 5,173 | +8.8% | 0.15% | -5.2% |
| Q4 2017 | $387,000 | +1.8% | 4,756 | +3.9% | 0.15% | -1.9% |
| Q3 2017 | $380,000 | +9.2% | 4,576 | +5.4% | 0.16% | +1.9% |
| Q2 2017 | $348,000 | +23.4% | 4,343 | +11.1% | 0.15% | +24.2% |
| Q1 2017 | $282,000 | +84.3% | 3,909 | +78.2% | 0.12% | +61.0% |
| Q4 2016 | $153,000 | -25.4% | 2,193 | -19.1% | 0.08% | -42.5% |
| Q3 2016 | $205,000 | +10.2% | 2,712 | +15.1% | 0.13% | +4.7% |
| Q2 2016 | $186,000 | +53.7% | 2,357 | +33.9% | 0.13% | +64.1% |
| Q1 2016 | $121,000 | +112.3% | 1,760 | +151.8% | 0.08% | +100.0% |
| Q4 2015 | $57,000 | +9.6% | 699 | +20.5% | 0.04% | +8.3% |
| Q3 2015 | $52,000 | -13.3% | 580 | -10.6% | 0.04% | -5.3% |
| Q2 2015 | $60,000 | – | 649 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |